Capillary Electrophoresis Market (2026 - 2033)

Capillary Electrophoresis Market Summary

The global capillary electrophoresis market size was valued at USD 388.3 million in 2025 and is projected to grow from USD 408.0 million in 2026 to USD 595.4 million in 2033, at a CAGR of 5.5% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 34.0% in 2025. The global market growth is driven by increasing applications in drug discovery, pharmacokinetics, biomarker identification, clinical diagnostics, and biopharmaceutical analysis.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Furthermore, increasing R&D spending in drug discovery and development and a rising number of clinical laboratories are likely to drive the market growth over the forecast period. Capillary electrophoresis (CE) is increasingly utilized in drug discovery, pharmacokinetics, and biomarker identification due to its high resolution, sensitivity, and ability to separate complex mixtures of biomolecules.

As pharmaceutical companies focus on precision medicine and personalized therapies, CE plays a crucial role in understanding molecular interactions and disease mechanisms. For instance, Sebia's CAPILLARYS 3 OCTA is an automated capillary electrophoresis platform designed for clinical laboratory applications across myeloma, diabetes, hemoglobinopathies, and chronic alcohol abuse testing. Its scalable configuration and broad assay menu demonstrate the growing adoption of automated CE platforms for high-throughput clinical diagnostics.

The increasing prevalence of chronic diseases such as cardiovascular disorders, diabetes, and various types of cancer is driving demand for CE's. Its high resolution and ability to separate complex mixtures of biomolecules, such as proteins, nucleic acids, and carbohydrates, make it invaluable in identifying disease-specific markers that traditional methods may overlook. In clinical settings, CE facilitates the detection and quantification of biomarkers indicative of chronic diseases such as cardiovascular disorders, diabetes, and various cancers. The technique enables rapid and accurate profiling of patient samples, aiding early diagnosis, disease monitoring, and personalized treatment strategies.

Technological advancements in capillary coatings, fluorescence detection, mass spectrometry coupling, automation, and data-analysis software are improving the sensitivity, throughput, reproducibility, and workflow efficiency of CE systems. The shift towards minimally invasive diagnostics and point-of-care testing further drives the adoption of CE technologies. In addition, Recent technological innovations by manufacturers in capillary coatings, detection systems (e.g., fluorescence detection, mass spectrometry coupling), and automation have improved CE's throughput, sensitivity, and reproducibility.

The capillary electrophoresis industry is characterized by several key players, including Agilent Technologies, Thermo Fisher Scientific, and PerkinElmer. These companies focus on product innovation, strategic collaborations, and mergers/acquisitions to expand their product portfolios and enhance market presence. In addition, emerging companies and startups are introducing niche CE systems targeting specific applications or technological enhancements, contributing to market dynamism.

Governments' initiatives, increasing funding, and substantial investments are driving the market growth. Further, research organizations worldwide are allocating significant funds to biotechnology and life sciences research, including investments in CE technologies. Funding initiatives aim to accelerate research in areas such as genomics and proteomics, thereby driving market growth. Government funding programs support research initiatives focused on advancing capillary electrophoresis technologies. Funds are directed towards basic research, applied sciences, and translational research aimed at improving healthcare outcomes, environmental monitoring, and agricultural sciences. These investments play a crucial role in driving technological innovations and expanding the utility of capillary electrophoresis across diverse fields.

Analyst Perspective

The capillary electrophoresis market is supported by increasing demand for high-resolution, automated analytical techniques across clinical diagnostics, pharmaceutical research, biotechnology, and biopharmaceutical quality control. CE provides rapid separation with low sample and reagent requirements, making it suitable for protein characterization, nucleic acid analysis, biomarker assessment, and therapeutic development. Continued advances in automated instrumentation, fluorescence detection, software, and consumables are improving workflow efficiency and analytical reproducibility. Growing investment in biologics, personalized medicine, and complex biomolecule characterization is expected to sustain demand for CE platforms and associated consumables over the forecast period.

Product Insights

The consumables segment held the largest market share of around 71.0% in 2025 and is also anticipated to grow at the fastest CAGR over the forecast period. This high growth is attributed to their essential role in the regular operation and maintenance of CE systems. These include capillaries, reagents, buffers, and sample vials, which need frequent replacement to ensure optimal performance and accurate results. The continuous need for consumables creates a steady revenue stream for manufacturers, making them a significant market driver. In addition, advancements in consumable technologies, such as enhanced reagent sensitivity and specificity, further drive the growth and adoption of CE systems across diagnostics, pharmaceuticals, and research.

Novel capillary coatings are being explored to enhance separation efficiency, resolution, and reproducibility in CE. These include dynamic coatings added to the running buffer and covalently bonded static coatings on the inner capillary surface. Manufacturers are introducing dynamically coated capillaries for easier method development. Such as PVA-coated capillaries from Agilent Technologies.

The instrument segment is anticipated to witness significant growth over the forecast period. The market is driven by advancements in biotechnology, pharmaceutical research, clinical diagnostics, and food safety. Key instruments include Beckman Colter PA 800 Plus, Agilent 7100, SCIEX CESI 8000 Plus, and Bio-Rad BioFocus 2000. These systems address the need for precise and efficient analytical techniques.

Mode Insights

The capillary gel electrophoresis segment held the largest market share, at around 49.0%, in 2025. Advancements in CGE are enabling more efficient protein characterization, purity analysis, and aggregate detection, which are crucial for the development and quality control of biopharmaceuticals. Integrated CGE platforms with streamlined workflows and higher sample throughput are increasing the productivity and efficiency of electrophoresis-based analyses. Furthermore, making capillary electrophoresis more feasible for academic, clinical, and commercial laboratories. Integrated CGE platforms with streamlined workflows and higher sample throughput are improving laboratory productivity and expanding adoption across academic, clinical, pharmaceutical, and biotechnology laboratories. Advances in automated platforms and microchip-based electrophoresis are further extending the range of applications for CGE.

The capillary electrochromatography segment is anticipated to grow at the fastest CAGR over the forecast period. Owing to its unique ability to combine high efficiency with enhanced selectivity, it is particularly valuable for complex sample analysis. The technique's growth is further fueled by increasing demand in pharmaceutical research, proteomics, and environmental monitoring. Technological advancements, such as improved column materials, miniaturization, and integration with mass spectrometry, are expanding CEC's capabilities and applications. The push for more sensitive and specific analytical methods in drug development, personalized medicine, and forensic science is also driving the adoption of CEC. In addition, the technique's low sample and solvent requirements align well with the growing emphasis on sustainable and cost-effective laboratory practices.

Application Insights

The nucleic acid segment accounted for the largest market share of around 28.0% in 2025, supported by growing demand for DNA and RNA analysis across genetic research, molecular diagnostics, and biopharmaceutical applications. Capillary electrophoresis enables high-resolution separation and sizing of nucleic acid fragments, making it valuable for quality control, genotyping, sequencing workflows, and biomolecular characterization. Increasing automation and demand for higher-throughput molecular analysis continue to support adoption across research and diagnostic laboratories.

The protein analysis segment is anticipated to grow at the fastest CAGR over the forecast period. The ability of CE to provide high-resolution separation and quantification of proteins, including post-translational modifications and complex mixtures, makes it invaluable. Recent advancements in CE technology, such as improved detection methods and automation, have enhanced its accuracy and efficiency. These innovations meet the growing demand for detailed protein characterization, driving significant market expansion in this segment.

End Use Insights

The research organizations and institutes segment held the largest market share, at around 52.0%, in 2025. Research organizations and institutes play a crucial role in advancing the market. They drive innovation by developing new methodologies and applications for CE, thereby enhancing its capabilities in fields such as genomics, proteomics, and clinical diagnostics. These entities often collaborate with industry leaders to translate scientific discoveries into commercial products, fostering technological advancements. In addition, they provide critical validation and standardization of CE techniques.

The pharmaceutical and biotechnology companies segment is anticipated to grow at a substantial CAGR over the forecast period. The pharmaceutical and biotechnology companies have a profound impact on the market, driving innovation, demand, and application development. These industries are major end users of CE technology, particularly in drug discovery, quality control, and biopharmaceutical analysis. Their substantial R&D investments and need for high-resolution, high-throughput analytical techniques push the boundaries of CE capabilities. The growing focus on biologics, personalized medicine, and stringent regulatory requirements has further increased CE adoption in areas such as protein characterization, impurity profiling, and chiral separations. Pharmaceutical companies’ method development efforts often set industry standards, while their global presence influences CE market trends globally.

Regional Insights

The capillary electrophoresis industry in North America dominated with a revenue share of approximately 34.0% in 2025. This high share is attributed to the increasing prevalence of chronic diseases in the region, coupled with the rising demand for personalized medicine in North America, as the need for precise and individualized treatment options. Capillary electrophoresis (CE) systems play a crucial role in this field due to their ability to analyze complex biological samples quickly and accurately. Key players in the region are pursuing strategic initiatives, including product launches, mergers, and acquisitions, to serve a wide range of clients.

To learn more about this report, Download Free Sample Report

U.S. Capillary Electrophoresis Market Trends

The capillary electrophoresis industry in the U.S. is expected to grow substantially over the forecast period. Increasing demand in pharmaceutical research, clinical diagnostics, and forensic applications. The market is expected to continue expanding due to technological advancements and growing adoption in various fields. Capillary electrophoresis (CE) has significantly improved the accuracy of disease diagnosis in the U.S. by providing a rapid, high-throughput, and sensitive analytical technique. Government support through funding for biotechnology research further boosts the market growth.

Europe Capillary Electrophoresis Market Trends

The capillary electrophoresis industry in Europe was identified as a lucrative region in this industry. Owing to advancements in biotechnology and increasing demand for precise diagnostic tools. This growth is fueled by applications in clinical diagnostics, pharmaceuticals, and research laboratories. The market benefits from innovations in microfluidic technology, which enhance the efficiency and accuracy of molecular analysis. Key players in this market include Agilent Technologies, Bio-Rad Laboratories, and PerkinElmer, who are driving advancements and meeting the demand for high-performance analytical instruments. Europe’s strong focus on research and development further propels this market forward.

The UK’s capillary electrophoresis industry is experiencing steady growth, driven by advancements in molecular diagnostics and increasing demand for precise analytical techniques in clinical and research settings. The rising prevalence of chronic diseases, such as cancer and genetic disorders, is fueling the adoption of capillary electrophoresis for protein and nucleic acid analysis. In addition, the growing focus on personalized medicine and biomarker discovery is boosting its use in pharmaceutical research. Key players in the UK are introducing innovative instruments and reagents, enhancing workflow automation and sensitivity. Academic institutions and diagnostic laboratories are also increasingly adopting this technology due to its versatility and accuracy, further contributing to market growth.

The capillary electrophoresis industry in Germany is growing, driven by advances in biotechnology and rising demand for precise analytical tools in clinical diagnostics and research. The country's strong pharmaceutical and biotechnology sectors are key drivers of capillary electrophoresis adoption in applications such as protein analysis, DNA sequencing, and quality control. Rising investments in research and development, coupled with a focus on personalized medicine and biomarker discovery, are further boosting market growth. In addition, the adoption of automated, high-throughput capillary electrophoresis systems in academic and diagnostic laboratories is enhancing efficiency and accuracy, making capillary electrophoresis a preferred choice for various analytical applications in Germany.

The France capillary electrophoresis industry is growing due to increased demand for advanced diagnostic and analytical tools in clinical and research applications. The focus on personalized medicine, coupled with advancements in biotechnology, is driving the adoption of capillary electrophoresis for protein and DNA analysis. In addition, the rise in research funding and the integration of automation in laboratories are further enhancing the market's growth prospects in France.

Asia Pacific Capillary Electrophoresis Market Trends

The capillary electrophoresis industry in Asia Pacific is anticipated to witness the fastest CAGR over the forecast period. This is due to the rising incidence of cancer and infectious diseases in Asia Pacific, which is likely driving the adoption of advanced diagnostic technologies such as capillary electrophoresis, and increasing industry-academia collaborations in countries like India, China, and Japan. Factors that drive growth include increasing investments in pharmaceutical and biotechnology research, rising demand for personalized therapeutics, and a growing number of clinical and research laboratories in the region.

China’s capillary electrophoresis industry is expanding rapidly, driven by the country's growing biotechnology and pharmaceutical industries. Increased research funding, along with a rising focus on genetic research, disease diagnostics, and personalized medicine, is fueling demand for capillary electrophoresis. The technology is widely used for protein and nucleic acid analysis in both academic and clinical settings. In addition, the integration of automated systems and advancements in diagnostic technologies are improving the efficiency and accuracy of capillary electrophoresis, further supporting market growth in China.

The capillary electrophoresis industry in Japan is experiencing growth, driven by the country's strong healthcare infrastructure and advancements in biotechnology. The increasing focus on precision medicine, genetic research, and early disease detection is boosting the demand for capillary electrophoresis, particularly for protein and DNA analysis. In addition, the adoption of automated systems and high-throughput capabilities in research and diagnostic laboratories is enhancing testing efficiency. Japan’s aging population and rising rates of chronic disease are further contributing to the growing need for advanced diagnostic tools, thereby supporting market expansion.

Latin America Capillary Electrophoresis Market Trends

The capillary electrophoresis industry in Latin America is experiencing gradual growth, driven by increasing demand for advanced diagnostic tools in clinical and research applications. Rising investment in healthcare infrastructure, particularly in countries such as Brazil and Mexico, is boosting the adoption of capillary electrophoresis for protein analysis, genetic testing, and disease diagnostics. In addition, the growing focus on personalized medicine and biomarker research is fueling market demand. As research institutions and diagnostic laboratories in the region adopt more automated and efficient systems, the market is expected to expand further, improving the accessibility and accuracy of capillary electrophoresis techniques.

The Brazil capillary electrophoresis industry is expanding as demand for advanced diagnostic and research tools increases. The growing focus on personalized medicine, genetic research, and disease diagnostics is driving the adoption of capillary electrophoresis, particularly for protein and DNA analysis. Brazil's increasing investments in healthcare infrastructure and research are further supporting market growth. In addition, the rise in chronic diseases and the need for accurate, efficient diagnostic methods are driving demand for capillary electrophoresis in clinical settings. The integration of automation and high-throughput systems in laboratories is enhancing testing efficiency and precision, further fueling market expansion.

Middle East & Africa Capillary Electrophoresis Market Trends

The capillary electrophoresis industry in Middle East and Africa (MEA) is witnessing steady growth, driven by advancements in clinical diagnostics and rising demand for precision medicine. Key trends include increased adoption of automated systems for high-throughput analysis and integration with next-generation sequencing technologies. For instance, Beckman Coulter's PA 800 Plus and Agilent's 7100 CE system are widely used for protein characterization and DNA sequencing. The growing prevalence of genetic disorders and cancer in the region is spurring demand for robust analytical tools. In addition, partnerships between diagnostic labs and healthcare providers are enhancing accessibility to cutting-edge electrophoresis technologies.

The Saudi Arabia capillary electrophoresis industry is growing steadily, driven by advancements in the healthcare and biotechnology sectors. The increasing focus on genetic research, personalized medicine, and disease diagnostics is boosting the demand for capillary electrophoresis, particularly in protein and DNA analysis. Saudi Arabia's significant investments in healthcare infrastructure and research are further fueling market growth. In addition, the rising prevalence of chronic diseases, such as cancer and genetic disorders, is contributing to the adoption of more advanced diagnostic technologies. The integration of automation in laboratories is also enhancing the efficiency and accuracy of capillary electrophoresis, supporting its broader use in the country.

Key Capillary Electrophoresis Company Insights

Some of the key players operating in the market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., and Shimadzu Corporation. The market is highly competitive, with a large number of manufacturers accounting for a majority of the share. New-source development, mergers and acquisitions, and collaborations are among the major strategies adopted by these players to counter stiff competition.

Key Capillary Electrophoresis Companies:

The following key companies have been profiled for this study on the capillary electrophoresis market.

• C.B.S Scientific

• Danaher

• Helena Laboratories

• QIAGEN

• Thermo Fisher Scientific Inc.

• Agilent Technologies Inc.

• Bio-Rad Laboratories Inc.

• Bio-Techne

• PerkinElmer Inc.

• Merck KGaA

• Shimadzu Corporation

Recent Developments

• In September 2025, SCIEX launched native fluorescence detection for the BioPhase 8800 system, enhancing capillary electrophoresis assays such as CE-SDS and cIEF for protein therapeutics. The new detection capability improves sensitivity and enables clearer detection of low-abundance peaks, supporting protein characterization and quality assessment in biopharmaceutical development.

• In January 2024, Agilent Technologies launched the ProteoAnalyzer system, an automated parallel capillary electrophoresis platform designed for protein analysis. The system automates protein separation and data processing while simplifying sample preparation, supporting higher workflow efficiency and reproducibility across protein characterization and quality-control applications.

Global Capillary Electrophoresis Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global capillary electrophoresis market report based on product, mode, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Instrument

  • Automatic Capillary Electrophoresis Systems

  • Semi-Automatic Capillary Electrophoresis Systems

  • Consumables

  • Software

  • Mode Outlook (Revenue, USD Million, 2021 - 2033)

    • Capillary zone electrophoresis

    • Capillary gel electrophoresis

    • Capillary electrochromatography

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Nucleic acid analysis

  • Protein analysis

  • Genomic DNA

  • Plasmid DNA

  • Fragment Analysis

  • RNA/mRNA Analysis

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Research Organizations and Institutes

  • Pharmaceutical & Biotechnology Companies

  • Clinical laboratories

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Sweden

    • Denmark

    • Spain

    • Italy

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • Kuwait

    • UAE

    • Saudi Arabia

    • South Africa